Showing results (71-80 of 315) with videos related to
Sort By:
Pageof 32
Anti-Cancer Drugs|August 7, 2001
Sequence-dependent cytotoxicity of combination chemotherapy using paclitaxel, carboplatin and bleomycin in human lung and ovarian cancerC N Waltmire, D S Alberts, R T DorrLancet (London, England)|May 1, 1976
Doxorubicin/B.C.N.U. chemotherapy for multiple myeloma in relapseD S Alberts, B G Durie, S E SalmonCancer Chemotherapy and Pharmacology|January 1, 1983
Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assayM S Aapro, D S Alberts, S E SalmonProgress in Clinical and Biological Research|January 1, 1980
Development of a bioassay for ovarian carcinoma colony-forming cellsA W Hamburger, S E Salmon, D S AlbertsCancer Chemotherapy and Pharmacology|January 1, 1980
The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouseR T Dorr, D S Alberts, H S ChenCancer Treatment Reports|May 1, 1977
Treatment of multiple myeloma in remission with anticancer drugs having cell cycle specific characteristicsD S Alberts, B G Durie, S E SalmonJournal of the National Cancer Institute|January 1, 1987
Analysis and stability of retinol in plasmaY M Peng, M J Xu, D S AlbertsCancer Research|March 1, 1982
Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assayD S Alberts, C Mackel, R Pocelinko, et al.Seminars in Oncology|September 1, 1985
In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by intraperitoneal administrationD S Alberts, L Young, N Mason, et al.Journal of Medicinal Chemistry|October 1, 1991
Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: new reductive alkylating DNA cleaving agentsI Islam, E B Skibo, R T Dorr, et al.Pageof 32